Cargando…
Correlation of IgG autoantibodies against acetylcholine receptors and desmogleins in patients with pemphigus treated with steroid sparing agents or rituximab
INTRODUCTION: Autoantibodies (autoAbs) against desmoglein-1 (DSG1) and desmoglein-3 (DSG3) have conventionally been studied and well accepted in the pathogenesis of pemphigus vulgaris (PV) and foliaceus (PF). Recent studies have suggested that non-DSG autoAbs may contribute to the pathogenesis of pe...
Autores principales: | Bhatia, Sravya M., Streilein, Robert D., Hall, Russell P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302486/ https://www.ncbi.nlm.nih.gov/pubmed/32555697 http://dx.doi.org/10.1371/journal.pone.0233957 |
Ejemplares similares
-
Faster IgG4 Depletion Kinetics Observed for Anti-Desmoglein 3 Autoantibodies Following Rituximab Treatment in Patients with Pemphigus Vulgaris
por: BOCH, Katharina, et al.
Publicado: (2022) -
Pathogenicity and Epitope Characteristics Do Not Differ in IgG Subclass-Switched Anti-Desmoglein 3 IgG1 and IgG4 Autoantibodies in Pemphigus Vulgaris
por: Lo, Agnes S., et al.
Publicado: (2016) -
Autoantibodies against desmoglein 2 are not pathogenic in pemphigus()
por: Miguel, Marcela Calixto Brandão, et al.
Publicado: (2022) -
Endocytosis of IgG, Desmoglein 1, and Plakoglobin in Pemphigus Foliaceus Patient Skin
por: Oktarina, Dyah A. M., et al.
Publicado: (2019) -
Autoantibodies other than Anti-desmogleins in Pemphigus Vulgaris Patients
por: Saleh, Marwah Adly, et al.
Publicado: (2017)